VirTra (NASDAQ:VTSI) reported quarterly earnings of $0.07 per share. This is a 40 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $8.00 million which beat the analyst consensus estimate of $6.28 million by 27.39 percent. This is a 52.24 percent increase over sales of $5.25 million the same period last year.
Deciphera Pharmaceuticals Q3 EPS $(0.55) Beats $(0.58) Estimate, Sales $35.97M Beat $33.15M Estimate
Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.58) by 5.17 percent. This is a 59.85 percent increase over losses of $(1.37) per
